ahlam1399
09-26-2015, 12:27 PM
FDA revokes approval for Sun Pharma?s seizure drug over compliance issues
MUMBAI (Reuters) - The U.S. Food and Drug Administration has revoked an approval issued in March to India's Sun Pharma Advanced Research Company Ltd (SPARC) to launch a drug for seizures, citing manufacturing quality problems at its production site.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4a2e13c7/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=W_bXuObhnTc:fiEQoSu1GeY:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=W_bXuObhnTc:fiEQoSu1GeY:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=W_bXuObhnTc:fiEQoSu1GeY:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=W_bXuObhnTc:fiEQoSu1GeY:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=W_bXuObhnTc:fiEQoSu1GeY:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/W_bXuObhnTc
MUMBAI (Reuters) - The U.S. Food and Drug Administration has revoked an approval issued in March to India's Sun Pharma Advanced Research Company Ltd (SPARC) to launch a drug for seizures, citing manufacturing quality problems at its production site.
http://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4a2e13c7/sc/21/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=W_bXuObhnTc:fiEQoSu1GeY:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=W_bXuObhnTc:fiEQoSu1GeY:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=W_bXuObhnTc:fiEQoSu1GeY:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=W_bXuObhnTc:fiEQoSu1GeY:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=W_bXuObhnTc:fiEQoSu1GeY:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/W_bXuObhnTc